Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Margaret A. Piron"'
Autor:
Brandon C. Farmer, Holden C. Williams, Nicholas A. Devanney, Margaret A. Piron, Grant K. Nation, David J. Carter, Adeline E. Walsh, Rebika Khanal, Lyndsay E. A. Young, Jude C. Kluemper, Gabriela Hernandez, Elizabeth J. Allenger, Rachel Mooney, Lesley R. Golden, Cathryn T. Smith, J. Anthony Brandon, Vedant A. Gupta, Philip A. Kern, Matthew S. Gentry, Josh M. Morganti, Ramon C. Sun, Lance A. Johnson
Publikováno v:
Molecular Neurodegeneration, Vol 16, Iss 1, Pp 1-18 (2021)
Abstract Background Cerebral glucose hypometabolism is consistently observed in individuals with Alzheimer’s disease (AD), as well as in young cognitively normal carriers of the Ε4 allele of Apolipoprotein E (APOE), the strongest genetic predictor
Externí odkaz:
https://doaj.org/article/cb9c5a3aaabd427e887297119cecd36d
Autor:
Holden C. Williams, Brandon C. Farmer, Margaret A. Piron, Adeline E. Walsh, Ronald C. Bruntz, Matthew S. Gentry, Ramon C. Sun, Lance A. Johnson
Publikováno v:
Neurobiology of Disease, Vol 136, Iss , Pp 104742- (2020)
The Apolipoprotein E (APOE) gene is a major genetic risk factor associated with Alzheimer's disease (AD). APOE encodes for three main isoforms in humans (E2, E3, and E4). Homozygous E4 individuals have more than a 10-fold higher risk for developing l
Externí odkaz:
https://doaj.org/article/7589f30a37d84420b9e630cacea2dd7f
Autor:
Holden C. Williams, Margaret A. Piron, Grant K. Nation, Adeline E. Walsh, Lyndsay E. A. Young, Ramon C. Sun, Lance A. Johnson
Publikováno v:
Metabolites, Vol 10, Iss 12, p 501 (2020)
Stable isotope-resolved metabolomics (SIRM) is a powerful tool for understanding disease. Advances in SIRM techniques have improved isotopic delivery and expanded the workflow from exclusively in vitro applications to in vivo methodologies to study s
Externí odkaz:
https://doaj.org/article/3f3d40d074544e3fa09a3c8ed3e8da6a
Autor:
Holden C. Williams, Grant K. Nation, Matthew S. Gentry, Vedant Gupta, Rebika Khanal, Gabriela Hernandez, Josh M. Morganti, David J. Carter, Jude C. Kluemper, Philip A. Kern, Margaret A. Piron, J. Anthony Brandon, Lance A. Johnson, Elizabeth J. Allenger, Lyndsay E.A. Young, Rachel Mooney, Brandon C. Farmer, Ramon C. Sun, Nicholas Devanney, Adeline E. Walsh
Cerebral glucose hypometabolism is consistently observed in individuals with Alzheimer’s disease (AD), as well as in young cognitively normal carriers of the E4 allele of Apolipoprotein E (APOE), the strongest genetic predictor of late-onset AD. Wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::843e687dc1e905d1665c4b231f0b5463
https://doi.org/10.1101/2020.10.19.345991
https://doi.org/10.1101/2020.10.19.345991
Autor:
Holden C. Williams, Margaret A. Piron, Ronald C. Bruntz, Matthew S. Gentry, Adeline E. Walsh, Ramon C. Sun, Brandon C. Farmer, Lance A. Johnson
Publikováno v:
Neurobiol Dis
Neurobiology of Disease, Vol 136, Iss, Pp 104742-(2020)
Neurobiology of Disease, Vol 136, Iss, Pp 104742-(2020)
The Apolipoprotein E (APOE) gene is a major genetic risk factor associated with Alzheimer's disease (AD). APOE encodes for three main isoforms in humans (E2, E3, and E4). Homozygous E4 individuals have more than a 10-fold higher risk for developing l